Disease & disorder

homocystinuria due to methylene tetrahydrofolate reductase deficiency

MONDO:0009353

Homocystinuria due to methylene tetrahydrofolate reductase (MTHFR) deficiency is a metabolic disorder characterized by neurological manifestations.

Outbreak surveillance

Global reported events

Explore recent public health notices potentially related to homocystinuria due to methylene tetrahydrofolate reductase deficiency. Results are keyword matches, not yet verified disease-to-outbreak relationships.

View homocystinuria due to methylene tetrahydrofolate reductase deficiency on the outbreak map →
Clinical trials1
Recruiting0
Drug concepts studied0
Synonyms9
Advertisement
Background context

Methylenetetrahydrofolate reductase deficiency

Methylenetetrahydrofolate reductase deficiency is the most common genetic cause of elevated serum levels of homocysteine (hyperhomocysteinemia). It is caused by genetic defects in MTHFR, which is an important enzyme in the methyl cycle. Common variants of MTHFR deficiency are asymptomatic and have only minor effects on disease risk. Severe variants (from nonsense mutations) are rare.

Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.

Drugs being studied

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.